Log In
BCIQ
Print this Print this
 

lersivirine (UK-453,061, UK-453061)

  Manage Alerts
Collapse Summary General Information
Company ViiV Healthcare Ltd.
DescriptionNon-nucleoside reverse transcriptase inhibitor (NNRTI)
Molecular Target
Mechanism of ActionNon-nucleoside reverse transcriptase inhibitor (NNRTI)
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/20/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today